Details for Shareholders
Shareholders should note that the Board meeting will be pivotal for the following reasons:
- The release of annual results is a major event in the company’s calendar, providing a comprehensive overview of QingSong Health Corporation’s financial health and strategic direction for the year 2025.
- The potential recommendation of a final dividend will be closely watched. Payment of a dividend can directly benefit shareholders and reflects the company’s profitability and confidence in its future cash flow. Conversely, if no dividend is recommended, it may signal caution or financial constraints.
- Any disclosures made after the Board meeting, including the annual results announcement and dividend decision, are likely to be price-sensitive and may trigger share price movements.
The timing of this announcement (March 10, 2026) gives investors advance notice, allowing them to prepare for possible volatility around the annual results publication and dividend declaration.
Board Composition
The Board consists of:
- Executive Directors: Ms. YANG Yin and Ms. WANG Jing
- Non-executive Directors: Mr. ZHAO Yuping, Mr. ZHENG Kaihuan, and Mr. WU Bin
- Independent Non-executive Directors: Dr. WANG Xiaoyan, Mr. CHOW Yiu Ming, and Mr. BAI Kun
This composition demonstrates a balance of leadership and oversight, which is important for corporate governance and investor confidence.
Disclaimer: This article is based on the official announcement made by QingSong Health Corporation. Investors should be aware that the actual impact on share price will depend on the details of the annual results and dividend decision, which will be disclosed after the upcoming Board meeting. This article does not constitute investment advice. Please consult your financial advisor before making any investment decisions.
View QINGSONG HEALTH Historical chart here
